Alemnew Birhan, Biazin Habtamu, Demis Asmamaw, Abate Reta Melese
Department of Medical Laboratory Sciences, College of Health Sciences, Woldia University, Woldia, Ethiopia.
Department of Microbiology, Immunology and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Int J Microbiol. 2020 Sep 10;2020:8853053. doi: 10.1155/2020/8853053. eCollection 2020.
The burden of bloodstream infections (BSIs) has been warranted in Ethiopia. Globally, the emergency and raised resistance rate of bacterial antimicrobial resistance is becoming a prominent problem, and it is difficult to treat patients having sepsis. In this review, we aimed to determine the pooled prevalence of bacterial isolates among presumptive patients with bloodstream infections in Ethiopia.
A systematic search was performed from PubMed/MEDLINE, Scopus, HINARI, ScienceDirect, and Google Scholar electronic databases using PRISMA guidelines. The data analysis was carried out using STATA version 14 after the records were cleaned and sorted out.
A total of 26 studies with 8,958 blood specimens and 2,382 culture-positive bacterial isolates were included for systematic review and meta-analysis. The meta-analysis derived a pooled culture-positive bacterial prevalence which was 25.78% (95% CI: 21.55-30.01%). The estimated pooled prevalence of Gram-positive and Gram-negative bacterial isolates was 15.50% (95% CI: 12.84-18.15%) and 10.48 % (95% CI: 8.32-12.63%), respectively. The two common Gram-positive bacteria isolated from patients suspected of BSIs were coagulase-negative with a pooled prevalence of 5.75% (95% CI: 4.58-6.92%) and 7.04 % (95% CI: 5.37-8.72%). Similarly, the common Gram-negative bacterial isolates and their estimated pooled prevalence were 1.69% (95% CI: 1.21-2.16%), species 7.04 % (95% CI: 5.37-8.72%), species 0.39% (95% CI: 0.08-0.70%), species 1.09% (95% CI: 0.79-1.38%), and 0.88% (95% CI: 0.54-1.22%).
The prevalence of bacterial isolates among presumptive patients suspected to BSIs in Ethiopia remains high. Furthermore, we found a remarkable variation in the pathogen distribution across the study setting.
埃塞俄比亚血流感染(BSIs)的负担已得到确认。在全球范围内,细菌抗菌药物耐药性的紧急情况和不断上升的耐药率正成为一个突出问题,治疗败血症患者也变得困难。在本综述中,我们旨在确定埃塞俄比亚疑似血流感染患者中细菌分离株的合并患病率。
按照PRISMA指南,在PubMed/MEDLINE、Scopus、HINARI、ScienceDirect和谷歌学术电子数据库中进行系统检索。在对记录进行清理和整理后,使用STATA 14版进行数据分析。
共有26项研究纳入了8958份血液标本和2382株培养阳性细菌分离株,进行系统评价和荟萃分析。荟萃分析得出合并培养阳性细菌患病率为25.78%(95%CI:21.55 - 30.01%)。革兰氏阳性和革兰氏阴性细菌分离株的估计合并患病率分别为15.50%(95%CI:12.84 - 18.15%)和10.48%(95%CI:8.32 - 12.63%)。从疑似BSIs患者中分离出的两种常见革兰氏阳性菌是凝固酶阴性菌,合并患病率分别为5.75%(95%CI:4.58 - 6.92%)和7.04%(95%CI:5.37 - 8.72%)。同样,常见的革兰氏阴性细菌分离株及其估计合并患病率分别为1.69%(95%CI:1.21 - 2.16%)、某菌种7.04%(95%CI:5.37 - 8.72%)、某菌种0.39%(95%CI:0.08 - 0.70%)、某菌种1.09%(95%CI:0.79 - 1.38%)和0.88%(95%CI:0.54 - 1.22%)。
埃塞俄比亚疑似BSIs患者中细菌分离株的患病率仍然很高。此外,我们发现不同研究环境中病原体分布存在显著差异。